Normally, NIH would be a key partner in starting trials to test vaccine candidates amid an Ebola outbreak.
But the division that would have done that work "is now gone," says a former NIHer. That could slow eventual approval, even with a major infusion of cash from CEPI
www.npr.org/2026/06/04/g...
There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo. Trials are going on for several candidates. How long will it take?
